We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$789M
AUM Growth
-$30.8M
Cap. Flow
-$19.4M
Cap. Flow %
-2.46%
Top 10 Hldgs %
49.57%
Holding
138
New
14
Increased
15
Reduced
36
Closed
14

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$7.4M
2
AAPL icon
Apple
AAPL
+$2.4M
3
ABT icon
Abbott
ABT
+$552K
4
SNY icon
Sanofi
SNY
+$536K
5
NKE icon
Nike
NKE
+$529K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.06M
2
SLB icon
SLB Ltd
SLB
+$5.21M
3
MO icon
Altria Group
MO
+$4.49M
4
PM icon
Philip Morris
PM
+$4.4M
5
MDLZ icon
Mondelez International
MDLZ
+$2.49M

Sector Composition

Rank Sector Weight
1 Financials 26.52%
2 Healthcare 21.36%
3 Industrials 14.67%
4 Technology 13.3%
5 Communication Services 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB icon
1
Chubb
CB
$137B
$52.9M 6.7%
404,409
-4,508
-1% -$556K
TMO icon
2
Thermo Fisher Scientific
TMO
$198B
$43.8M 5.56%
296,734
-41,089
-12% -$6.06M
GE icon
3
GE Aerospace
GE
$364B
$42.3M 5.37%
280,592
-6,911
-2% -$1.01M
DHR icon
4
Danaher
DHR
$144B
$40.2M 5.1%
592,654
-6,026
-1% -$394K
CMCSA icon
5
Comcast
CMCSA
$85B
$39.5M 5.01%
1,211,002
-11,520
-0.9% -$358K
ORCL icon
6
Oracle
ORCL
$364B
$36.6M 4.64%
893,351
-2,010
-0.2% -$80.3K
AIG icon
7
American International
AIG
$42.7B
$36M 4.57%
681,148
-1,770
-0.3% -$97.7K
AGN
8
DELISTED
Allergan plc
AGN
$34.6M 4.39%
149,849
+32,092
+27% +$7.4M
MSFT icon
9
Microsoft
MSFT
$2.93T
$32.6M 4.14%
637,222
-3,728
-0.6% -$194K
UPS icon
10
United Parcel Service
UPS
$100B
$32.3M 4.09%
299,709
-4,706
-2% -$490K
AAPL icon
11
Apple
AAPL
$4.9T
$30.8M 3.91%
1,290,488
+96,664
+8% +$2.4M
APTV icon
12
Aptiv
APTV
$12.2B
$30.7M 3.89%
490,538
+2,340
+0.5% +$164K
MET icon
13
MetLife
MET
$60.5B
$27M 3.42%
759,529
-5,495
-0.7% -$214K
CIT
14
DELISTED
CIT Group Inc.
CIT
$26M 3.3%
815,511
-9,510
-1% -$309K
JPM icon
15
JPMorgan Chase
JPM
$907B
$25.1M 3.19%
404,175
+1,640
+0.4% +$102K
C icon
16
Citigroup
C
$217B
$23M 2.92%
543,687
-5,032
-0.9% -$223K
CELG
17
DELISTED
Celgene Corp
CELG
$22.4M 2.84%
227,031
-795
-0.3% -$82.2K
SLB icon
18
SLB Ltd
SLB
$70.3B
$22M 2.79%
277,788
-68,020
-20% -$5.21M
DAL icon
19
Delta Air Lines
DAL
$55.4B
$19.9M 2.53%
546,569
-1,085
-0.2% -$46.1K
WHR icon
20
Whirlpool
WHR
$2.48B
$18.1M 2.3%
108,755
+1,150
+1% +$203K
JCI icon
21
Johnson Controls International
JCI
$85.7B
$18M 2.29%
388,795
-859
-0.2% -$37.8K
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.22T
$16.6M 2.1%
479,300
+3,860
+0.8% +$139K
GOOGL icon
23
Alphabet (Google) Class A
GOOGL
$4.23T
$15.6M 1.97%
442,240
-200
-0% -$7.34K
KMI icon
24
Kinder Morgan
KMI
$71.9B
$9.08M 1.15%
485,036
+1,700
+0.4% +$30.3K
GILD icon
25
Gilead Sciences
GILD
$167B
$7.59M 0.96%
91,007
-215
-0.2% -$19.1K

Similar funds

Cannell & Spears's Q2 2016 Portfolio in Review

As of Q2 2016, Cannell & Spears held 138 positions worth $789M, down 3.8% from $819M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cannell & Spears's Q2 2016 filing shows 14 new, 15 increased, 36 reduced and 14 closed positions. Its largest new stake was Abbott: 13,873 shares worth $545K. The largest sale was Thermo Fisher Scientific, an estimated $6.06M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Cannell & Spears's largest Q2 2016 buy was Abbott: 13,873 shares worth $545K.
  • Cannell & Spears added most to Allergan plc in Q2 2016, an estimated $7.4M increase.
  • Cannell & Spears's biggest Q2 2016 reduction was Thermo Fisher Scientific, cutting an estimated $6.06M.
  • Cannell & Spears fully exited Kraft Heinz in Q2 2016, selling an estimated $1.56M.
  • Cannell & Spears's ten largest holdings make up 50% of its $789M portfolio in Q2 2016.
  • Cannell & Spears opened 14 new positions and closed 14 in Q2 2016.
  • Cannell & Spears's portfolio value fell 3.8% quarter-over-quarter to $789M.

Based on Cannell & Spears's 13F filing for Q2 2016, filed 10 Aug 2016.